Kestra Private Wealth Services’s Definium Therapeutics DFTX Stock Holding History

Kestra Private Wealth Services’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.38M	Hold	50,588	–	–	0.03%	543
2026 Q1	$956K	Buy	50,588 +448	+0.9%	+$7.6K	0.01%	862
2025 Q4	$671K	Hold	50,140	–	–	0.01%	1007
2025 Q3	$591K	Hold	50,140	–	–	0.01%	1027
2025 Q2	$325K	Sell	50,140 -66	-0.1%	-$434	﹤0.01%	1237
2025 Q1	$294K	Sell	50,206 -1,000	-2%	-$7.16K	﹤0.01%	1214
2024 Q4	$356K	Sell	51,206 -133	-0.3%	-$915	0.01%	1071
2024 Q3	$292K	Hold	51,339	–	–	0.01%	1091
2024 Q2	$370K	Hold	51,339	–	–	0.01%	958
2024 Q1	$483K	Hold	51,339	–	–	0.01%	811
2023 Q4	$188K	Hold	51,339	–	–	﹤0.01%	1110
2023 Q3	$161K	Hold	51,339	–	–	0.01%	1053
2023 Q2	$183K	Hold	51,339	–	–	0.01%	975
2023 Q1	$163K	Sell	51,339 -133	-0.3%	-$442	0.01%	952
2022 Q4	$113K	Buy	51,472 +1,000	+2%	+$2.78K	0.01%	840
2022 Q3	$177K	Buy	+50,472	New	+$485K	0.01%	801

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Kestra Private Wealth Services's DFTX Position: Q2 2026 in Review

Kestra Private Wealth Services held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 50,588 shares worth $2.38M. The position accounts for 0.03% of the portfolio, ranked #543.

Kestra Private Wealth Services first reported a position in DFTX in Q3 2022 and has held it in 16 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Kestra Private Wealth Services held 50,588 shares of Definium Therapeutics worth $2.38M as of Q2 2026.
Kestra Private Wealth Services left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up 0.03% of Kestra Private Wealth Services's portfolio in Q2 2026, its #543 holding.
Kestra Private Wealth Services first reported a position in Definium Therapeutics in Q3 2022 and has held it in 16 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.